Evaluation of Thyroid Functions in Patients with Multiple Sclerosis Before and after Treatment with Interferon Beta

Magda Shokry Mohammed, N. Shoeib, I. Sabry, D. Gawad, A. Bahaaeldin, N. Adly
{"title":"Evaluation of Thyroid Functions in Patients with Multiple Sclerosis Before and after Treatment with Interferon Beta","authors":"Magda Shokry Mohammed, N. Shoeib, I. Sabry, D. Gawad, A. Bahaaeldin, N. Adly","doi":"10.4172/2167-7948.1000227","DOIUrl":null,"url":null,"abstract":"Background: Multiple sclerosis (MS) is a multi-component disease characterized by inflammation, neurodegeneration and failure of central nervous system (CNS) repair mechanisms. Autoimmune thyroid disease is a frequently studied disorder in MS, most studies have focused primarily on the increased prevalence of thyroid dysfunction and anti-thyroid antibodies (ATAs) in MS patients compared with a control population.Objectives: To investigate the effect of treatment with interferon beta on thyroid functions and autoimmune thyroid markers in patients with multiple sclerosis.Subjects and Methods: This prospective study was conducted on 100 subjects recruited from the inpatient and outpatient clinic of Internal Medicine department and Neurology Unit of Ain Shams University Hospitals. They were divided into group 1, which included 50 patients newly diagnosed with multiple sclerosis according to Macdonald’s criteria 2010 and group 2, which included 50, age and sex matched healthy volunteers. All participants were exposed before and 6 months after treatment with interferon beta to Expanded disability status scale (EDSS), which is a method of quantifying disability in multiple sclerosis, Free T4, Free T3 and TSH, Anti thyroid peroxidase (anti- TPO) and anti-thyroglobulin (anti TG) antibodies, MRI brain and neck ultrasonography.Results: Anti thyroid peroxidase antibody levels were significantly higher in the drug naive patients group after treatment with interferon beta (29.660 ± 28.755 IU/ml) in comparison to their baseline values (17.580 ± 4.982 IU/ml) (p-value=0.004). Anti-thyroglobulin antibody levels were significantly higher too after treatment with interferon beta (33.920 ± 32.553 IU/ml) in comparison to baseline values (24.560 ± 20.101 IU/ml) (p- value=0.01).Conclusion: IFN-β therapy has a strong impact on the auto-immune thyroid markers status and levels in drug naive MS patients causing increase in both anti TPO and anti TG positivity statues and numerical values.","PeriodicalId":91565,"journal":{"name":"Journal of thyroid disorders & therapy","volume":"7 1","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thyroid disorders & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-7948.1000227","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Multiple sclerosis (MS) is a multi-component disease characterized by inflammation, neurodegeneration and failure of central nervous system (CNS) repair mechanisms. Autoimmune thyroid disease is a frequently studied disorder in MS, most studies have focused primarily on the increased prevalence of thyroid dysfunction and anti-thyroid antibodies (ATAs) in MS patients compared with a control population.Objectives: To investigate the effect of treatment with interferon beta on thyroid functions and autoimmune thyroid markers in patients with multiple sclerosis.Subjects and Methods: This prospective study was conducted on 100 subjects recruited from the inpatient and outpatient clinic of Internal Medicine department and Neurology Unit of Ain Shams University Hospitals. They were divided into group 1, which included 50 patients newly diagnosed with multiple sclerosis according to Macdonald’s criteria 2010 and group 2, which included 50, age and sex matched healthy volunteers. All participants were exposed before and 6 months after treatment with interferon beta to Expanded disability status scale (EDSS), which is a method of quantifying disability in multiple sclerosis, Free T4, Free T3 and TSH, Anti thyroid peroxidase (anti- TPO) and anti-thyroglobulin (anti TG) antibodies, MRI brain and neck ultrasonography.Results: Anti thyroid peroxidase antibody levels were significantly higher in the drug naive patients group after treatment with interferon beta (29.660 ± 28.755 IU/ml) in comparison to their baseline values (17.580 ± 4.982 IU/ml) (p-value=0.004). Anti-thyroglobulin antibody levels were significantly higher too after treatment with interferon beta (33.920 ± 32.553 IU/ml) in comparison to baseline values (24.560 ± 20.101 IU/ml) (p- value=0.01).Conclusion: IFN-β therapy has a strong impact on the auto-immune thyroid markers status and levels in drug naive MS patients causing increase in both anti TPO and anti TG positivity statues and numerical values.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
干扰素β治疗前后多发性硬化症患者甲状腺功能的评价
背景:多发性硬化症(MS)是一种多组分疾病,以炎症、神经退行性变和中枢神经系统(CNS)修复机制失效为特征。自身免疫性甲状腺疾病是多发性硬化症中一种经常研究的疾病,大多数研究主要集中在与对照人群相比,多发性痴呆症患者甲状腺功能障碍和抗甲状腺抗体(ATA)的患病率增加。目的:研究干扰素β治疗对多发性硬化症患者甲状腺功能和自身免疫性甲状腺标志物的影响。受试者和方法:这项前瞻性研究对100名来自艾因沙姆斯大学医院内科和神经科住院和门诊的受试者进行。他们被分为第一组和第二组,第一组包括50名根据2010年麦克唐纳标准新诊断为多发性硬化症的患者,第二组包括50岁、年龄和性别匹配的健康志愿者。所有参与者在干扰素β治疗前和治疗后6个月均暴露于扩展残疾状态量表(EDSS),这是一种量化多发性硬化症残疾的方法,游离T4、游离T3和TSH,抗甲状腺过氧化物酶(抗TPO)和抗甲状腺球蛋白(抗TG)抗体,MRI脑和颈部超声。结果:与基线值(17.580±4.982 IU/ml)(p值=0.004)相比,未用药患者组在干扰素β治疗后的抗甲状腺过氧化物酶抗体水平(29.660±28.755 IU/ml)显著更高基线值(24.560±20.101IU/ml)(p值=0.01)。结论:IFN-β治疗对未用药的MS患者自身免疫甲状腺标志物状态和水平有很大影响,导致抗TPO和抗TG阳性状态和数值增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Papillary Thyroid Cancer: Is Surgical Operation Constantly Vital? Levothyroxine studies from National Health Survey Thyroid Gland Functions and Hyperthyroidism Clinical Profiles of Males with Graves' Disease: A Two Year Review in a Tertiary Hospital in Nigeria Current Approach on Thyroid Research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1